natera.com is a domain
that was created on 2003-04-25,making it 22 years ago.
It has several subdomains, such as investor.natera.com
connect.natera.com , among others.
Description:Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about...
Discover natera.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 395.169 KB |
Page Load Time: 0.707007 Seconds |
Website IP Address: 13.227.74.66 |
Natera Connect |
Natera, Inc. | Investor Relations |
Generic Cell Phone Accessories | Cell-phone-accessories |
Institute for Integrative Biology of the Cell – I2BC, Institute of Integrative Biology of the Cell, |
Sauce Labs: Cross Browser Testing, Selenium Testing & Mobile Testing |
DNA Diagnostics Center - DNA Testing Paternity Prenatal |
Dog DNA Test, Dog Breed Test - Wisdom Panel Canine DNA Testing | Wisdom Panel B2B |
Rxight® Genetic Testing | CLIA Certified Pharmacogenetic | DNA Testing |
AncestryDNA® | DNA Tests for Ethnicity & Genealogy DNA Test |
Cell Phone Search NumLookup - Free Reverse Cell Phone |
Natera: A global leader in cell-free DNA testing https://www.natera.com/ |
Natera Portal Hub | Natera https://www.natera.com/natera-portal-hub/ |
About Us | Natera https://www.natera.com/company/about-us/ |
Contact Us | Natera https://www.natera.com/company/contact-us/ |
Women's Health | Women's Health Testing | Natera https://www.natera.com/womens-health/ |
Natera, Inc. | Investor Relations https://investor.natera.com/overview/default.aspx |
Unified patient portal https://my.natera.com/ |
Careers | Natera https://www.natera.com/company/careers/ |
Natera Client portal https://clientportal.natera.com/ |
Women's Health Pricing & Billing | Natera https://www.natera.com/womens-health/pricing-billing/ |
Our Technology | Natera https://www.natera.com/company/our-technology/ |
FDA Grants Two New Breakthrough Device Designations for Natera's ... https://www.natera.com/company/news/fda-grants-two-new-breakthrough-device-designations-for-nateras-signatera-mrd-test-2/ |
Oncology | Natera https://www.natera.com/oncology/ |
NateraCore Services | Natera https://www.natera.com/womens-health/core-services/ |
Genetic Carrier Screening | Natera https://www.natera.com/womens-health/horizon-advanced-carrier-screening/ |
A natera.com. 60 IN A 18.245.60.8 |
AAAA natera.com. 60 IN AAAA 2600:9000:20db:9c00:a:c669:ef80:93a1 |
MX natera.com. 1577 IN MX 1 aspmx.l.google.com. |
NS natera.com. 21600 IN NS ns-1484.awsdns-57.org. |
SOA natera.com. 900 IN SOA ns-506.awsdns-63.com. awsdns-hostmaster.amazon.com. 1 7200 900 1209600 86400 |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Date: Mon, 13 May 2024 12:32:24 GMT |
Set-Cookie: AWSALB=Y/r9FY/Q7buQ5GBbzt+lI7S143fbjBq8VRFuBRccsVKQ+lCEuzKuSLp/aXlNHI72zSwj0y+Hgue3roxM+X5MUG/WQGErU7dWRE4f9KdVtrnsQW+EiWx8XNVgkezK; Expires=Mon, 20 May 2024 12:32:23 GMT; Path=/, AWSALBCORS=Y/r9FY/Q7buQ5GBbzt+lI7S143fbjBq8VRFuBRccsVKQ+lCEuzKuSLp/aXlNHI72zSwj0y+Hgue3roxM+X5MUG/WQGErU7dWRE4f9KdVtrnsQW+EiWx8XNVgkezK; Expires=Mon, 20 May 2024 12:32:23 GMT; Path=/; SameSite=None; Secure |
Server: nginx/1.24.0 |
Strict-Transport-Security: max-age=31536000 |
Content-Security-Policy: upgrade-insecure-requests |
X-Frame-Options: SAMEORIGIN |
X-Content-Type-Options: nosniff |
Vary: Accept-Encoding |
X-Cache: Hit from cloudfront |
Via: 1.1 1a6e1efe30d70fc3718c47f07ff0b6f0.cloudfront.net (CloudFront) |
X-Amz-Cf-Pop: LAX53-P2 |
X-Amz-Cf-Id: aSEDLPOsnDtwL1QACXDpFrZ92HMc29yoGE0yS09OYsUgmtFyvvgMag== |
Age: 80620 |
charset="utf-8"/ |
content="width=device-width, initial-scale=1.0, maximum-scale=5.0, user-scalable=1" name="viewport"/ |
content="IE=edge" http-equiv="X-UA-Compatible"/ |
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots" |
content="Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care." name="description"/ |
content="en_US" property="og:locale"/ |
content="website" property="og:type"/ |
content="Natera: A global leader in cfDNA testing" property="og:title"/ |
content="Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care." property="og:description"/ |
content="https://www.natera.com/" property="og:url"/ |
content="Natera" property="og:site_name"/ |
content="https://www.facebook.com/NateraGenetics" property="article:publisher"/ |
content="2024-04-29T23:32:51+00:00" property="article:modified_time"/ |
content="http://10.108.74.61/wp-content/uploads/2022/02/Natera-social.jpg" property="og:image"/ |
content="1200" property="og:image:width"/ |
content="627" property="og:image:height"/ |
content="image/jpeg" property="og:image:type"/ |
content="summary_large_image" name="twitter:card"/ |
content="@nateragenetics" name="twitter:site"/ |
content="Natera v.2.66.0" name="generator"/ |
content="NwBb33inw1hoaOoWfipuIk2b4cOqRG3NzsVKkBuwxWo" name="google-site-verification"/ |
content="l21ll3potpw22y53z7nq9hy6k87275" name="facebook-domain-verification"/ |
content="4965C11BCDDB2CD497F16FBBFE62D31B" name="msvalidate.01"/ |
content="https://www.natera.com/wp-content/uploads/2021/01/Natera_Favicon_32x32.png" property="og:logo" size="32x32"/ |
content="https://www.natera.com/wp-content/uploads/2021/01/Natera_Favicon_512x512.png" property="og:logo" size="512x512"/ |
content="https://www.natera.com/wp-content/uploads/2021/01/Natera_Favicon_32x32.png" name="msapplication-TileImage" |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
Pay Bill Portals Our Tests Oncology TESTS Signatera – Residual Disease Test (MRD) Altera – Tumor Genomic profile Empower – Hereditary Cancer Test FOR PATIENTS Signatera Patient Information Signatera for Colorectal Cancer Signatera for Bladder Cancer Signatera for Breast Cancer Signatera for Immunotherapy Signatera for Lung Cancer Signatera for Skin Cancers Signatera for Gynecologic Cancers FOR CLINICIANS Signatera Clinician Information Signatera for Colorectal Cancer Signatera for Bladder Cancer Signatera for Breast Cancer Signatera for Immunotherapy Signatera for Lung Cancer Signatera for Skin Cancers Signatera for Gynecologic Cancers Signatera Research Pipeline Oncology Portal Organ Health TESTS Prospera Kidney – Transplant Assessment Prospera Heart – Transplant Assessment Prospera Lung – Transplant Assessment Renasight – Kidney Gene Panel FOR PATIENTS Prospera for Kidney Patients Prospera for Heart Patients Prospera for Lung Patients Renasight Patient Information Pricing and Billing Information FOR CLINICIANS Prospera for Kidney Clinician Renasight Clinician Information Renasight Gene Conditions List Organ Health Portal Women’s Health TESTS Horizon – Advanced Carrier Screening Panorama – Noninvasive Prenatal Testing (NIPT) Empower – Hereditary Cancer Test Vistara – Single-Gene NIPT Anora – Miscarriage Test Spectrum – Preimplantation Genetics Vasistera – Limited Noninvasive Prenatal Testing (NIPT) FOR PATIENTS Pricing and Billing Information Women’s Health Portal FOR CLINICIANS NateraConnect Provider Portal Horizon Conditions List NEVA for Empower – Natera’s Educational Virtual Assistant Our Services Oncology SERVICES NateraCore Services Pharma Partnership EMR Integration FOR PATIENTS Schedule a Genetic Information Session Schedule Session with Patient Coordinator Pricing and Billing Information Contact Us FOR CLINICIANS Schedule Session With Client Services Oncology Portal Order a Test Kit Contact Us Organ Health SERVICES NateraCore Services ProReach EMR Integration FOR PATIENTS Schedule a Genetic Information Session Order a Renasight Kit Contact Us Pricing and Billing Information FOR CLINCIANS Organ Health Portal Order a Renasight Kit Contact Us Women’s Health SERVICES NateraCore Services Constellation EMR Integration FOR PATIENTS Schedule a Genetic Information Session Pricing and Billing Information Women’s Health Portal Contact Us FOR CLINICIANS Order Tests and Track Status on NateraConnect View Patient Results on NateraConnect Contact Us Patient Resources Oncology LEARN Blog Brochures Manuals Studies Videos View All Patient Resources EXISTING PATIENTS Schedule a Genetic Information Session Schedule Blood Draw (Existing Patients) Schedule Session with Patient Coordinator Pricing and Billing Information CONNECT Contact Us Organ Health LEARN Brochures Manuals Podcasts Reports Studies Videos View All Patient Resources EXISTING PATIENTS Schedule Blood Draw (Existing Patients) Schedule a Genetic Information Session Pricing and Billing Information CONNECT Contact Us Women’s Health LEARN Blog Brochures Manuals View All Patient Resources Videos Webinars EXISTING PATIENTS Schedule a Genetic Information Session Schedule Blood Draw (Existing Patients – USA) Schedule Blood Draw (Existing Patients – Canada) Pricing and Billing Information Women’s Health Portal CONNECT Contact Us Clinical Resources Oncology CLINICAL RESOURCES Peer-reviewed Publications Posters Blog Manuals Reports Videos Whitepapers View All Clinician Resources RESEARCH STUDIES Signatera Research Pipeline BESPOKE CRC BESPOKE IO CONNECT Oncology Portal Contact Us Organ Health CLINICAL RESOURCES Brochures Manuals Peer-reviewed Publications Podcasts Reports Studies Videos Webinars View All Clinician Resources RESEARCH STUDIES ProActive Study PEDAL Study Trifecta Study MOTR Study CONNECT Organ Health Portal Contact Us Women’s Health CLINICAL RESOURCES Blog Brochures Manuals Peer-reviewed Publications Webinars Videos Natera Academy Provider Education Hub View All Clinician Resources RESEARCH STUDIES CONNECT Contact Us CompanyOur People Our Technology News Events Careers Investor Relations ESG & Social Responsibility Contact Us Search for: Pay Bill Portals Click to show search bar Search for: Now Available: Fetal RhD NIPT Learn More Now Available: Fetal RhD NIPT Learn More Protect Health and Inform Earlier, More Targeted Interventions Natera’s cell-free DNA tests help inform more personalized health care decisions. Test Measure fetal, tumor, or donor cfDNA at the molecular level with a noninvasive test. Know Identify risk of disease, detect recurrence, and understand treatment responses. Decide Make more-informed health decisions for individualized care. Dedicated to Oncology, Women’s Health, and Organ Health Oncology Tests Characterize tumors, anticipate risk, and evaluate treatment response earlier than traditional tools. Hear Jeff’s story. Learn More Women’s Health Tests Identify risk of severe genetic conditions to help families prepare and inform early intervention that can improve outcomes. Hear Corrine’s story. Learn More Organ Health Tests Detect organ injury early and inform treatment strategy to improve transplant health. Hear Gigi’s story. Learn More Innovating with Integrity Innovating with Integrity Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making. Our tests are clinically validated in over 200 peer-reviewed publications with over 3 million patients studied. We participated in the largest prospective studies to date in molecular diagnostics in oncology ( CIRCULATE ), women’s health ( SMART ), and organ health ( Trifecta ). We meet or exceed applicable industry and regulatory standards for all of our tests to deliver high-quality results, and have processed over 10 million tests in our CAP/CLIA‑certified labs. We have more than 150 medical professionals on staff who provide expert support to help make our test results clear and easy to understand. Creating a World of Possibilities Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making. Natera News May 09, 2024 Natera Reports First Quarter 2024 Financial Results Read More May 03, 2024 New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera ™ in Breast Cancer Read More May 01, 2024 Natera to Report its First Quarter 2024 Results on May 9 Read More View All News Looking for more information? Let us help you find your way I am a select clinician patient researcher looking for tests and resources for select oncology organ health women’s health Show me Our Tests Oncology Organ Health Women’s Health Our Services Oncology Core Organ Health Core Women’s Health Core Patient Resources Resource Library Pricing & Billing Pay Bill Patient Portals Clinical Resources Resource Library Provider Portals CompanyOur People Our Technology News Events Careers Investor Relations Social Responsibility Contact Contact Us Schedule Blood Draw (Existing Patients – USA) Schedule Blood Draw (Existing Patients – Canada) Schedule a Genetic Information Session Natera Licenses IT Security Compliance Notice of Data Collection for California Residents Do Not Share My Personal Information Privacy Practices Privacy Policy Terms of Use Sitemap Designed by Elegant Themes | Powered by WordPress The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights Reserved. icon-angle icon-bars...
Domain Name: NATERA.COM Registry Domain ID: 97208278_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.registrar.amazon.com Registrar URL: http://registrar.amazon.com Updated Date: 2024-03-21T23:10:59Z Creation Date: 2003-04-25T18:09:06Z Registry Expiry Date: 2025-04-25T18:09:06Z Registrar: Amazon Registrar, Inc. Registrar IANA ID: 468 Registrar Abuse Contact Email: abuse@amazonaws.com Registrar Abuse Contact Phone: +1.2024422253 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1484.AWSDNS-57.ORG Name Server: NS-1891.AWSDNS-44.CO.UK Name Server: NS-506.AWSDNS-63.COM Name Server: NS-962.AWSDNS-56.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T13:36:33Z <<<